Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis

BACKGROUND: Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) are remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC). However, the individual role of EGFR‐TKIs in patients with brain metastasis (BM) arising from EGFR‐mutant NSCLC remains unclear. M...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thorac Cancer
Hlavní autoři: Zhang, Qiuyi, Zhang, Xuchao, Yan, Honghong, Jiang, Benyuan, Xu, Chongrui, Yang, Jinji, Chen, Zhihong, Su, Jian, Wu, Yi‐Long, Zhou, Qing
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons Australia, Ltd 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093172/
https://ncbi.nlm.nih.gov/pubmed/27755835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12379
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky